Involvement of the Primary Healthcare professionals in the Colorectal Cancer Screening Programme of the Basque Country
e202101012
Keywords:
Colorectal cancer, Early detection of cancer, Primary Healthcare, General practitioner, Nurse, ScreeningAbstract
Background: The Basque Government (Spain) approved a population based Colorectal Cancer Screening Programme in 2008 with its base on Primary Healthcare. Since then, a coverage of 100% of the population and an average participation rate of 68.4% have been achieved. General Practitioners and nurses play a central role on its implementation. The aim of this work was to describe the characteristics, involvement and attitudes of the health professionals that implement the programme.
Methods: A cross-sectional descriptive study was conducted in Primary Healthcare to general practitioners and nurses between May and June of 2016. An ad-hoc online questionnaire was designed. The data included socio-demographic information and questions regarding their involvement on the programme.
Results: 1,216 health professionals answered the questionnaire, 50.7% were general practitioners and 49.3% nurses. 78% of the responders were women. The 75.8% considered the programme very important although differences were found between general practitioners and nurses. The 89% of the professionals attended training and 34% scientific workshops about screening at least once. There were differences between general practitioners and nurses on the attendance to the training and importance they give to the programme, and on their participation on workshops.
Conclusions: There is a high level of involvement of Primary Healthcare professionals in the programme as they consider it very important; this could be one of the keys for its success. The differences between professionals on their opinion and experience should be taken into account on its design, as they are the ones with a closer contact with the population.
Downloads
References
Ferlay J, Steliarova-Foucher E, Lortet-Tieulent J et al. Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012. Eur J Cancer 2013;49:1374-1403. https://doi.org/10.1016/j.ejca.2012.12.027
World Health Organization. Cancer control: knowledge into action: WHO guide for effective programmes. World Health Organization; 2007. [Accessed 5/12/2019] Available from: https://www.who.int/cancer/modules/en/
Hewitson P, Glasziou Paul P, Irwig L et al. Screening for colorectal cancer using the faecal occult blood test, Hemoccult. Cochrane Database of Systematic Reviews. 2007;1:CD001216. https://doi.org/10.1002/14651858.CD001216.pub2
Gil L, de Castro V, Molinuevo A et al. Supervivencia de Cáncer en la Comunidad Autónoma Vasca 2000-2012. Department of Health, Basque Government. 2018.
Report from the commission to the European parliament, the council, the European economic and social committee and the committee of the regions. Implementation of the Communication from the Commission, from 24 June 2009, on Action Against Cancer: European Partnership [COM (2009) 291 final] and Second Implementation Report on the Council Recommendation of 2 December 2003 on cancer screening (2003/878/EC).
Spanish Ministry of Health and Social Policy. Cancer Strategy of the Spanish National Health System. Ministry of Health and Social Policy; 2010.
Boletín Oficial del Estado. Orden SSI/2065/2014, de 31 de octubre, por la que se modifican los anexos I, II y III del Real Decreto 1030/2006, de 15 de septiembre, por el que se establece la cartera de servicios comunes del Sistema Nacional de Salud y el procedimiento para su actualización. BOE núm. 269, de 6-11-2014.
Idígoras I, Arrospide A, Portillo I et al. Evaluation of the colorectal cancer screening Programme in the Basque Country (Spain) and its effectiveness based on the Miscan-colon model. BMC Public Health 2017;18:78. https://doi.org/10.1186/s12889-017-4639-3
Moss S, Ancelle-Park R, Brenner H. European guidelines for quality assurance in colorectal cancer screening and diagnosis. First Edition Evaluation and interpretation of screening outcomes. Endoscopy 2012;44:SE64. https://doi.org/10.1055/s-0032-1309788
Power E, Miles A, Von Wagner C et al. Uptake of colorectal cancer screening: System, provider and individual factors and strategies to improve participation. Future Oncology 2009;5:1371-1388. https://doi.org/10.2217/fon.09.134
Van Dam L, Korfage IJ, Kuipers EJ et al. What influences the decision to participate in colorectal cancer screening with faecal occult blood testing and sigmoidoscopy? Eur J Cancer 2013;49:2321-2330. https://doi.org/10.1016/j.ejca.2013.03.007
Wools A, Dapper EA, de Leeuw JR. Colorectal cancer screening participation: A systematic review. Eur J Public Health 2016;26:156. https://doi.org/10.1093/eurpub/ckv148
Chapple A, Ziebland S, Hewitson P et al. What affects the uptake of screening for bowel cancer using a faecal occult blood test (FOBt): a qualitative study. Soc Sci Med 2008;66:2425-2435. https://doi.org/10.1016/j.socscimed.2008.02.009
Steele RJ, Rey J, Lambert R. European guidelines for quality assurance in colorectal cancer screening and diagnosis. First Edition. Professional requirements and training. Endoscopy. 2012;44:SE115. https://doi.org/10.1055/s-0032-1309796
Seeff LC, Nadel MR, Klabunde CN et al. Patterns and predictors of colorectal cancer test use in the adult U.S. population. Cancer 2004;100:2093-2103. https://doi.org/10.1002/cncr.20276
Klabunde CN, Vernon SW, Nadel MR et al. Barriers to Colorectal Cancer Screening: A Comparison of Reports from Primary Care Physicians and Average-Risk Adults. Med Care. 2005;43:939-944. https://doi.org/10.1097/01.mlr.0000173599.67470.ba
Guessous I, Dash C, Lapin P, Doroshenk M, Smith RA, Klabunde CN. Colorectal cancer screening barriers and facilitators in older persons. Prev Med. 2010;50:3-10.
https://doi.org/10.1016/j.ypmed.2009.12.005
Beydoun HA, Beydoun MA. Predictors of colorectal cancer screening behaviors among average-risk older adults in the United States. Cancer Causes Control. 2008;19:339-359. https://doi.org/10.1007/s10552-007-9100-y
Weiss JM, Smith MA, Pickhardt PJ et al. Predictors of colorectal cancer screening variation among primary-care providers and clinics. Am J Gastroenterol. 2013;108:1159-1167. https://doi.org/10.1038/ajg.2013.127
Lafata JE, Cooper G, Divine G et al. Patient-physician colorectal cancer screening discussion content and patients’ use of colorectal cancer screening. Patient Educ Couns. 2014;94:76-82. https://doi.org/10.1016/j.pec.2013.09.008
Zapka JG, Puleo E, Vickers-Lahti M et al. Healthcare system factors and colorectal cancer screening. Am J Prev Med. 2002;23:28-35. https://doi.org/10.1016/S0749-3797(02)00444-0
Peterson EB, Ostroff JS, DuHamel KN et al. Impact of provider-patient communication on cancer screening adherence: A systematic review. Prev Med. 2016;93:96-105. https://doi.org/10.1016/j.ypmed.2016.09.034
Ponencia de Cribado Poblacional de la Comisión de Salud Pública. Documento marco sobre cribado poblacional. Ministry of Health, Social Services and Equality. Madrid; Spain. 2010.
Braithwaite D, Emery J, De Lusignan S et al. Using the Internet to conduct surveys of health professionals: a valid alternative? Fam Pract. 2003;20:545-551. https://doi.org/10.1093/fampra/cmg509
Cook C, Heath F, Thompson RL. A meta-analysis of response rates in web or internet-based surveys. Educ Psychol Meas. 2000;60:821-836. https://doi.org/10.1177/00131640021970934
Cho YI, Johnson TP, VanGeest JB. Enhancing surveys of health care professionals: a meta-analysis of techniques to improve response. Eval Health Prof. 2013;36:382-407. https://doi.org/10.1177/0163278713496425
Phillips AW, Friedman BT, Utrankar A et al. Surveys of health professions trainees: prevalence, response rates, and predictive factors to guide researchers. Acad Med. 2017;92:222-228. https://doi.org/10.1097/ACM.0000000000001334
Downloads
Published
How to Cite
Issue
Section
Categories
License
Copyright (c) 2021 Saloa Unanue-Arza, Eunate Arana-Arri, Isabel Portillo, Inmaculada Arostegui
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Usted es libre de:
Compartir — copiar y redistribuir el material en cualquier medio o formato.
La licenciante no puede revocar estas libertades en tanto usted siga los términos de la licencia.
Bajo los siguientes términos:
Atribución — Usted debe dar crédito de manera adecuada , brindar un enlace a la licencia, e indicar si se han realizado cambios. Puede hacerlo en cualquier forma razonable, pero no de forma tal que sugiera que usted o su uso tienen el apoyo de la licenciante.
NoComercial — Usted no puede hacer uso del material con propósitos comerciales.
SinDerivadas — Si remezcla, transforma o crea a partir del material, no podrá distribuir el material modificado.
No hay restricciones adicionales — No puede aplicar términos legales ni medidas tecnológicas que restrinjan legalmente a otras a hacer cualquier uso permitido por la licencia.
Avisos:
No tiene que cumplir con la licencia para elementos del material en el dominio público o cuando su uso esté permitido por una excepción o limitación aplicable.
No se dan garantías. La licencia podría no darle todos los permisos que necesita para el uso que tenga previsto. Por ejemplo, otros derechos como publicidad, privacidad, o derechos morales pueden limitar la forma en que utilice el material.
